231 – 240 of 329
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
New Approaches to Using FEIBA in the Treatment of Inhibitor Patients.
(
- Contribution to journal › Article
-
Mark
Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.
(
- Contribution to journal › Article
-
Mark
The next generation of hemophilia treatment specialists
(
- Contribution to journal › Article
-
Mark
Liposuction in Dercum's disease.
2006) p.516-518(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2005
-
Mark
Pharmacokinetic studies on Wilfactin((R)), a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods
(
- Contribution to journal › Article
-
Mark
Cost effectiveness of haemophilia treatment: a cross-national assessment.
(
- Contribution to journal › Article
-
Mark
Haemophilia Inhibitor Genetics Study - evaluation of a model for studies of complex diseases using linkage and association methods.
(
- Contribution to journal › Letter
-
Mark
Protein C levels can be forecasted by global haemostatic tests in critically ill patients and predict long-term survival.
(
- Contribution to journal › Article
-
Mark
Long-term prophylaxis in von Willebrand disease
(
- Contribution to journal › Article
-
Mark
Risk factors for venous thrombosis in Swedish children and adolescents.
(
- Contribution to journal › Article